Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 214
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07607964 A Study to Assess Adverse Events, How the Drug Moves Through the Body a… |
ABBV-519 | Lupus | Phase 1 | RECRUITING | En attente / non publié | AbbVie | United States, Japan · Advanced Quality Medical Resea… | 2026-05-28 → 2029-01 | Ouvrir |
| NCT07363590 A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthriti… |
MK-1045 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | Australia, Belgium, China, Colombia, Georgia, Italy, … | 2026-02-19 → 2029-07-16 | Ouvrir |
| NCT06948110 Deciphering the Genetic Architecture of Autoimmune Diseases |
Deciphering the Genetic Architect… | Lupus | À vérifier | RECRUITING | En attente / non publié | National Human Genome Research In… | United States, Peru · Amazon Rainforest, Lima, Peru |… | 2026-09-17 → 2030-04-22 | Ouvrir |
| NCT05637112 ASTER — A Treatment Effectiveness Study Among SLE Patients Receiving An… |
ASTER — A Treatment Effectiveness… | Lupus | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | Austria, Belgium, Canada, France, Germany, Israel, It… | 2023-02-27 → 2030-12-30 | Ouvrir |
| NCT07800871 FT839 in Autoimmune Diseases |
FT839 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Fate Therapeutics | United States · Providence Medical Foundation, Fuller… | 2026-10 → 2040-10 | Ouvrir |
| NCT07544225 CELL-ATTACK 1 — Study Investigating the Safety of Anti-CD19 CAR-T Cells… |
anti-CD19 CAR-T cells | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Gustave Roussy, Cancer Campus, Gr… | France · Gustave Roussy, Villejuif, France | 2026-12-01 → 2043-02-01 | Ouvrir |
| NCT07805863 Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic … |
Serum MPO-DNA Complexes as a Biom… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-10 → 2027-11 | Ouvrir |
| NCT00001372 Study of Systemic Lupus Erythematosus |
Study of Systemic Lupus Erythemat… | Lupus | À vérifier | RECRUITING | En attente / non publié | National Institute of Arthritis a… | United States · National Institutes of Health Clinica… | 1994-02-10 | Ouvrir |
| NCT06530849 A Study of GC012F Injection in Subjects With Refractory Systemic Lupus … |
GC012F Injection | Lupus | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Gracell Biotechnologies (Shanghai… | China · Research Site, Shanghai, China | Research Sit… | 2024-08-22 → 2027-02-01 | Ouvrir |
| NCT06875960 A Study to Continue the Administration of Deucravacitinib in Participan… |
BMS-986165 | Lupus | Phase 4 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States · Local Institution - 0001, Farmington,… | 2026-02-24 → 2028-01-31 | Ouvrir |
| NCT06717815 Phase IIa Study for IPG11406 in Patients With Lupus Nephritis |
IPG11406 | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Nanjing Immunophage Biotech Co., … | China · Fujian Medical University Union Hospital, Fuz… | 2025-02-25 → 2026-06-08 | Ouvrir |
| NCT07810569 Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic… |
Ocular Surface Changes and Meibom… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-10 → 2027-11 | Ouvrir |
| NCT06647069 A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Pat… |
SAR448501 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Sanofi | Australia, Bosnia and Herzegovina, New Zealand, South… | 2025-03-27 → 2029-06-25 | Ouvrir |
| NCT07814664 Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus… |
Ivarmacitinib Sulfate Tablets | Lupus | Phase 2/3 | NOT_YET_RECRUITING | En attente / non publié | Chinese SLE Treatment And Researc… | China · Peking Union Medical College Hospital, Beijin… | 2026-10-15 → 2028-09-30 | Ouvrir |
| NCT06475742 OPUS OLE — Long-term Safety and Tolerability of Cenerimod in Adults Wit… |
Cenerimod | Lupus | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | Viatris Innovation GmbH | United States, Argentina, Brazil, Bulgaria, Chile, Co… | 2024-07-30 → 2032-09 | Ouvrir |
| NCT06314282 INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anif… |
INTERSTELLAR - International Stud… | Lupus | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | Argentina, China, Costa Rica, Egypt, Guatemala, Kazak… | 2024-10-22 → 2027-12-31 | Ouvrir |
| NCT06925542 A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Re… |
CTX112 | Lupus | Phase 1 | RECRUITING | En attente / non publié | CRISPR Therapeutics | United States, Germany, Spain · Boston Medical Center… | 2025-03-10 → 2031-12-31 | Ouvrir |
| NCT06411249 A Study Describing the Efficacy and Safety of Belimumab Administered in… |
Belimumab (GSK1550188) | Lupus | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | GlaxoSmithKline | United States, Argentina, Brazil, France, Germany, Gr… | 2024-06-06 → 2029-07-17 | Ouvrir |
| NCT07570862 RECLAIM-LN — A Phase 2, Open-Label, Single-Arm Trial of FT819 in Partic… |
FT819 | Lupus | Phase 2 | RECRUITING | En attente / non publié | Fate Therapeutics | United States · Cross Creek Medical Clinic, Fayettevi… | 2026-07-27 → 2030-01-31 | Ouvrir |
| NCT06581198 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus… |
rapcabtagene autoleucel | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Austria, Brazil,… | 2024-09-04 → 2032-02-06 | Ouvrir |
| NCT07215663 Clinical Study of Cizutamig in Systemic Lupus Erythematosus |
Cizutamig | Lupus | Phase 1 | RECRUITING | En attente / non publié | Candid Therapeutics | China · Chinese Academy of Medical Sciences and Pekin… | 2025-09-04 → 2028-04 | Ouvrir |
| NCT06659029 PRIMULA_Preg — Prospective Registry Investigating Maternal and Infant O… |
Anifrolumab | Lupus | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | United States · Research Site, Wilmington, United Sta… | 2025-07-01 → 2031-04-15 | Ouvrir |
| NCT07791199 Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO… |
Deucravacitinib | Lupus | Phase 3 | NOT_YET_RECRUITING | En attente / non publié | Bristol-Myers Squibb | Non communiqué | 2026-12-31 → 2030-10-31 | Ouvrir |
| NCT02633163 Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus… |
Low Dose Mesenchymal Stem Cells (… | Lupus | Phase 2 | COMPLETED | En attente / non publié | Medical University of South Carol… | United States · Cedars-Sinai Medical Center, Los Ange… | 2018-11-18 → 2026-02-03 | Ouvrir |
| NCT06711887 Phase III Extension Study of Efficacy and Safety of Ianalumab With or W… |
Ianalumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Brazil, China, Colombia, Czechia, Fran… | 2025-05-19 → 2035-08-01 | Ouvrir |